Search research articles
Contact Us
Filters
Showing results (161-170 of 187) with videos related to
Page
of 19
Sort By:
Cancer Treatment Reports
|
January 1, 1983
Role of radiation therapy in small cell anaplastic carcinoma of the lung
N M Bleehen, P A Bunn, J D Cox, et al.
Lancet (London, England)
|
October 14, 1989
Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation
W P Sheridan, G Morstyn, M Wolf, et al.
Lancet (London, England)
|
March 14, 1992
Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy
W P Sheridan, C G Begley, C A Juttner, et al.
The Journal of Biological Chemistry
|
March 5, 1986
Assignment of methylene proton resonances in NMR spectra of embryonic and transformed cells to plasma membrane triglyceride
G L May, L C Wright, K T Holmes, et al.
Seminars in Oncology
|
August 1, 1993
Comparison of preparative transplantation regimens using carmustine/etoposide/cisplatin or busulfan/etoposide/cyclophosphamide in lymphoid malignancies
P Crilley, H Lazarus, D Topolsky, et al.
Bone Marrow Transplantation
|
January 1, 1993
Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy
A Grigg, C G Begley, C A Juttner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1992
High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma
H M Lazarus, P Crilley, N Ciobanu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2000
Enhancement of platelet recovery after myelosuppressive chemotherapy by recombinant human megakaryocyte growth and development factor in patients with advanced cancer
R L Basser, C Underhill, I Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2000
Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF
O N Koç, S L Gerson, B W Cooper, et al.
European Journal of Cancer & Clinical Oncology
|
November 1, 1983
On the receiving end--II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy
A Coates, C F Dillenbeck, D R McNeil, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 187) with videos related to
Sort By:
Page
of 19
Cancer Treatment Reports
|
January 1, 1983
Role of radiation therapy in small cell anaplastic carcinoma of the lung
N M Bleehen, P A Bunn, J D Cox, et al.
Lancet (London, England)
|
October 14, 1989
Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation
W P Sheridan, G Morstyn, M Wolf, et al.
Lancet (London, England)
|
March 14, 1992
Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy
W P Sheridan, C G Begley, C A Juttner, et al.
The Journal of Biological Chemistry
|
March 5, 1986
Assignment of methylene proton resonances in NMR spectra of embryonic and transformed cells to plasma membrane triglyceride
G L May, L C Wright, K T Holmes, et al.
Seminars in Oncology
|
August 1, 1993
Comparison of preparative transplantation regimens using carmustine/etoposide/cisplatin or busulfan/etoposide/cyclophosphamide in lymphoid malignancies
P Crilley, H Lazarus, D Topolsky, et al.
Bone Marrow Transplantation
|
January 1, 1993
Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy
A Grigg, C G Begley, C A Juttner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1992
High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma
H M Lazarus, P Crilley, N Ciobanu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2000
Enhancement of platelet recovery after myelosuppressive chemotherapy by recombinant human megakaryocyte growth and development factor in patients with advanced cancer
R L Basser, C Underhill, I Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2000
Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF
O N Koç, S L Gerson, B W Cooper, et al.
European Journal of Cancer & Clinical Oncology
|
November 1, 1983
On the receiving end--II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy
A Coates, C F Dillenbeck, D R McNeil, et al.
Page
of 19